Advisor Group Holdings, Inc. Cidara Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.77 - $1.16 $590 - $889	767 Added 1.48%	52,642 $49,000
Q2 2023 Aug 10, 2023	BUY	$1.01 - $1.42 $13,104 - $18,424	12,975 Added 33.35%	51,875 $58,000
Q1 2023 May 12, 2023	BUY	$0.75 - $1.98 $29,175 - $77,022	38,900 New	38,900 $49,000
Q1 2022 May 04, 2022	BUY	$0.67 - $1.39 $8,040 - $16,680	12,000 Added 120.0%	22,000 $18,000
Q2 2021 Aug 02, 2021	BUY	$1.87 - $2.7 $18,700 - $27,000	10,000 New	10,000 $20,000
Q1 2021 May 13, 2021	SELL	$2.06 - $3.01 $25,331 - $37,013	-12,297 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.39 - $4.0 $29,389 - $49,188	12,297 New	12,297 $45,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.24B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.